Evidence map›Paper›PMID 40680134›Full record

ReviewScience advances2025

Acoustic technologies for the orchestration of cellular functions for therapeutic applications.

Ye He, Jianping Xia, John D H Mai, Neil Upreti, Luke P Lee, Tony Jun Huang

Abstract readReview
In one paragraph

Review in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. A Self-Immunoregulatory Nanosensitizer for Sonodynamic Cancer Therapy.Advanced materials (Deerfield Beach, Fla.) · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Enhancing cancer therapyLab on a chip · 2025
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ye HeThomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.ORCID 0000-0001-7363-1063
Jianping XiaThomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.ORCID 0000-0001-9902-0228
John D H MaiAlfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, CA 90089, USA.
Neil UpretiThomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.ORCID 0000-0002-0751-8174
Luke P LeeRenal Division and Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Harvard University, Boston, MA 02115, USA.ORCID 0000-0002-1436-4054
Tony Jun HuangThomas Lord Department of Mechanical Engineering and Materials Science, Duke University, Durham, NC 27708, USA.ORCID 0000-0003-1205-3313

Funding

Automated High-purity Exosome isolation-based AD diagnostics system (AHEADx)R01AG084098 · NIA · DUKE UNIVERSITY · PI Tony Jun Huang · 2023 to 2026
$3.1M
Acoustofluidic Separation of Placental Nanovesicle Subpopulations in Obstetrical DiseasesR01HD103727 · NICHD · STANFORD UNIVERSITY · PI HUANG, TONY JUN, SADOVSKY, YOEL · 2021 to 2025
$2.6M
An acoustofluidic device for diagnosing preclinical Alzheimer's diseaseR44AG063643 · NIA · ASCENT BIO-NANO TECHNOLOGIES, INC. · PI WANG, LIN · 2021 to 2022
$2.5M
Development of a digital acoustofluidic system for automating liquid handling in biomedical researchR01GM141055 · NIGMS · DUKE UNIVERSITY · PI HUANG, TONY JUN · 2021 to 2024
$1.9M
Development of a multifunctional, acoustofluidic 3D bioprinter with single-cell resolutionR01GM144417 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Zhenhua Tian · 2022 to 2026
$1.8M
Enabling Efficient, Fast, Biocompatible Exosome Separation via AcoustofluidicsR01GM132603 · NIGMS · DUKE UNIVERSITY · PI HUANG, TONY JUN · 2019 to 2022
$1.7M
Development of an acoustofluidic device for high-throughput 3D imaging and sorting of C. elegansR44OD024963 · OD · ASCENT BIO-NANO TECHNOLOGIES, INC. · PI WANG, LIN · 2022 to 2023
$1.7M
An Acoustofluidic Device for Biocompatible Platelet SeparationR44HL140800 · NHLBI · ASCENT BIO-NANO TECHNOLOGIES, INC. · PI WANG, LIN · 2021 to 2022
$1.5M
Three-Dimensional (3D) Acoustofluidic Scanning Nanoscope with Super Resolution and Large Field of ViewR01GM143439 · NIGMS · UNIVERSITY OF DAYTON · PI AGHA, IMAD, HUANG, TONY JUN · 2021 to 2024
$1.5M
NHLBI NIH HHS R44 HL140800NIA NIH HHS R01 AG084098NIA NIH HHS R44 AG063643NICHD NIH HHS R01 HD103727NIGMS NIH HHS R01 GM132603NIGMS NIH HHS R01 GM141055NIGMS NIH HHS R01 GM143439NIGMS NIH HHS R01 GM144417NIH HHS R44 OD024963
6 · The paper itself

Abstract

Mechanical forces constantly stimulate cellular functions and influence their response behaviors. Similar to how an orchestra's music synchronizes an audience, acoustic technologies have emerged as precise, contact-free tools to study cellular responses. These platforms generate forces at appropriate length and frequency scales, enabling precise interactions with cells. Recent advancements highlight their potential for regulating cellular functions, revealing both therapeutic promise and the need for further biochemical exploration. This review summarizes the progress in using acoustic technologies to orchestrate cellular functions in vitro through mechanical stimulation. We first introduce the main categories of acoustic platforms and their working principles in cellular research. Subsequently, we explore the fundamental mechanisms linking acoustics to specific cellular interactions. We then review recent applications of these technologies in precisely modulating cellular functions for therapeutic purposes. Last, we discuss strategies to enhance their performance and efficacy, along with their potential integration with other biomedical tools.

Indexed as

AcousticsAnimalsCell BiologyHumans

Identifiers

PMID40680134
PMCPMC12273796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.